![logo](/logos/002020.SZ.webp)
Zhejiang Jingxin Pharmaceutical Co., Ltd.
SZSE:002020.SZ
12.55 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 3,952.09 | 3,779.846 | 3,335.971 | 3,258.075 | 3,646.684 | 2,943.802 | 2,219.066 | 1,875.461 | 1,415.696 | 1,235.496 | 974.427 | 857.582 | 709.731 | 631.019 | 531.474 | 510.306 | 565.217 | 428.869 | 301.881 | 348.222 | 301.506 | 269.954 | 227.053 |
Cost of Revenue
| 2,048.318 | 1,766.149 | 1,472.785 | 1,273.328 | 1,273.429 | 1,034.681 | 911.947 | 864.404 | 698.745 | 659.772 | 574.438 | 559.599 | 522.428 | 442.407 | 367.278 | 361.265 | 439.042 | 310.739 | 204.591 | 261.42 | 220.844 | 208.897 | 185.919 |
Gross Profit
| 1,903.772 | 2,013.697 | 1,863.186 | 1,984.747 | 2,373.255 | 1,909.121 | 1,307.119 | 1,011.057 | 716.952 | 575.724 | 399.989 | 297.983 | 187.303 | 188.612 | 164.196 | 149.041 | 126.176 | 118.13 | 97.29 | 86.802 | 80.662 | 61.057 | 41.134 |
Gross Profit Ratio
| 0.482 | 0.533 | 0.559 | 0.609 | 0.651 | 0.649 | 0.589 | 0.539 | 0.506 | 0.466 | 0.41 | 0.347 | 0.264 | 0.299 | 0.309 | 0.292 | 0.223 | 0.275 | 0.322 | 0.249 | 0.268 | 0.226 | 0.181 |
Reseach & Development Expenses
| 371.786 | 367.061 | 329.331 | 259.242 | 254.104 | 242.019 | 164.301 | 110.313 | 74.425 | 53.831 | 42.797 | 37.772 | 15.833 | 14.911 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 65.918 | 60.103 | 60.231 | 72.338 | 69.343 | 59.057 | 58.541 | 46.819 | 44.292 | 35.73 | 34.214 | 25.709 | 21.139 | 17.145 | 60.233 | 64.877 | 48.258 | 38.729 | 26.343 | 20.772 | 17.817 | 13.715 | 9.078 |
Selling & Marketing Expenses
| 783.527 | 791.576 | 760.935 | 965.098 | 1,341.06 | 1,100.572 | 679.676 | 501.779 | 364.364 | 311.609 | 204.68 | 144.659 | 63.526 | 91.363 | 79.268 | 65.892 | 60.1 | 49.535 | 33.228 | 29.1 | 25.571 | 17.391 | 16.104 |
SG&A
| 959.152 | 851.679 | 821.166 | 1,037.436 | 1,410.403 | 1,159.629 | 738.218 | 548.598 | 408.657 | 347.339 | 238.894 | 170.368 | 84.665 | 108.508 | 139.5 | 130.77 | 108.358 | 88.264 | 59.571 | 49.871 | 43.388 | 31.106 | 25.183 |
Other Expenses
| 6.352 | 135.656 | 99.759 | 114.691 | 172.118 | -0.852 | 231.919 | 19.419 | 13 | 4.796 | 12.731 | 5.003 | 6.952 | 4.509 | 4.471 | 10.139 | 12.073 | 2.889 | -5.907 | 2.614 | 0.695 | 2.664 | 0.966 |
Operating Expenses
| 1,324.586 | 1,354.396 | 1,250.256 | 1,411.368 | 1,836.625 | 1,537.208 | 1,029.465 | 769.757 | 555.232 | 456.755 | 326.567 | 250.13 | 137.346 | 157.511 | 143.643 | 134.217 | 111.242 | 90.957 | 61.318 | 50.725 | 44.504 | 32.358 | 25.63 |
Operating Income
| 579.186 | 756.616 | 692.961 | 765.386 | 602.063 | 416.293 | 118.744 | 236.266 | 186.09 | 124.396 | 62.976 | 36.333 | 29.746 | 9.923 | 3.879 | -20.332 | -9.961 | 15.795 | 30.875 | 32.341 | 32.01 | 25.604 | 14.807 |
Operating Income Ratio
| 0.147 | 0.2 | 0.208 | 0.235 | 0.165 | 0.141 | 0.054 | 0.126 | 0.131 | 0.101 | 0.065 | 0.042 | 0.042 | 0.016 | 0.007 | -0.04 | -0.018 | 0.037 | 0.102 | 0.093 | 0.106 | 0.095 | 0.065 |
Total Other Income Expenses Net
| 134.898 | -6.3 | 1.521 | -6.407 | 1.351 | 43.528 | 73.008 | 14.006 | 34.982 | 7.946 | 2.284 | -7.969 | -13.259 | -16.669 | -12.202 | -25.075 | -12.821 | -10.374 | -11.571 | -1.179 | -3.627 | -0.962 | -0.461 |
Income Before Tax
| 714.083 | 750.316 | 694.482 | 758.979 | 603.414 | 415.441 | 350.662 | 255.306 | 196.701 | 126.915 | 75.707 | 39.884 | 36.698 | 14.432 | 8.351 | -10.251 | 2.112 | 17.742 | 24.684 | 34.927 | 32.619 | 28.003 | 15.408 |
Income Before Tax Ratio
| 0.181 | 0.199 | 0.208 | 0.233 | 0.165 | 0.141 | 0.158 | 0.136 | 0.139 | 0.103 | 0.078 | 0.047 | 0.052 | 0.023 | 0.016 | -0.02 | 0.004 | 0.041 | 0.082 | 0.1 | 0.108 | 0.104 | 0.068 |
Income Tax Expense
| 84.623 | 82.493 | 79.778 | 105.652 | 81.466 | 43.954 | 83.636 | 38.577 | 30.084 | 19.835 | 11.359 | 8.205 | 7.579 | 1.472 | 4.379 | 8.004 | 0.658 | 7.27 | 6.23 | 9.136 | 7.214 | 5.72 | 5.435 |
Net Income
| 618.898 | 662.254 | 612.542 | 653.07 | 520.396 | 370.037 | 264.377 | 211.946 | 165.21 | 107.08 | 64.348 | 31.679 | 29.12 | 12.895 | 3.753 | -17.73 | 1.504 | 10.491 | 18.455 | 25.791 | 25.405 | 22.282 | 9.972 |
Net Income Ratio
| 0.157 | 0.175 | 0.184 | 0.2 | 0.143 | 0.126 | 0.119 | 0.113 | 0.117 | 0.087 | 0.066 | 0.037 | 0.041 | 0.02 | 0.007 | -0.035 | 0.003 | 0.024 | 0.061 | 0.074 | 0.084 | 0.083 | 0.044 |
EPS
| 0.72 | 0.77 | 0.75 | 0.83 | 0.64 | 0.43 | 0.33 | 0.26 | 0.24 | 0.17 | 0.11 | 0.052 | 0.058 | 0.027 | 0.008 | -0.037 | 0.003 | 0.029 | 0.057 | 0.058 | 0.077 | 0.067 | 0.05 |
EPS Diluted
| 0.72 | 0.77 | 0.75 | 0.83 | 0.64 | 0.43 | 0.33 | 0.26 | 0.24 | 0.17 | 0.11 | 0.052 | 0.058 | 0.027 | 0.008 | -0.037 | 0.003 | 0.029 | 0.057 | 0.058 | 0.077 | 0.067 | 0.05 |
EBITDA
| 800.652 | 939.471 | 863.597 | 881.102 | 731.089 | 520.934 | 619.846 | 357.522 | 266.575 | 186.969 | 133.844 | 100.442 | 97.524 | 72.734 | 68.543 | 69.204 | 55.382 | 52.595 | 43.392 | 48.383 | 42.822 | 31.746 | 19.403 |
EBITDA Ratio
| 0.203 | 0.249 | 0.259 | 0.27 | 0.2 | 0.177 | 0.279 | 0.191 | 0.188 | 0.151 | 0.137 | 0.117 | 0.137 | 0.115 | 0.129 | 0.136 | 0.098 | 0.123 | 0.144 | 0.139 | 0.142 | 0.118 | 0.085 |